Results 41 to 50 of about 18,335 (163)
Les mots du corps : une ethnographie des émotions des soignants en cancérologie [PDF]
peer reviewedIn a gynecological cancer unit, nurses and care assistants work together in treating their patients with a « global approach to the person ». Such an approach implies that the tumor, the body, the physical appearances, and the emotional well-
Bilhaut, Anne-Gaël
core
Abstract Canalicular adenoma (CA) is a benign salivary gland tumor predominantly affecting the upper lip and is characterized by monomorphic epithelial cells arranged in branching cords within a loose and vascularized stroma. Unlike pleomorphic adenoma (PA), CA lacks a chondroid matrix and exhibits specific histological features, such as high cuboidal ...
Ziyad Alsugair +8 more
wiley +1 more source
Essais précoces en cancérologie, éthique et justice [PDF]
National audienceC'est dans le cadre d'un programme de recherche sur l'égalité d'accès aux essais cliniques de cancérologie ("EgaliCan") que le symposium "Essais précoces en cancérologie : quelles définitions, quelle justice ?" s'est tenu au Collège de ...
Amiel, Philippe, Gateau, Valérie
core +2 more sources
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) [PDF]
Management of metastatic colorectal cancer requires a multimodal approach and must be performed by an experienced, multidisciplinary expert team. The optimal choice of the individual treatment modality, according to disease localization and extent, tumor
BASSO, ENRICO +15 more
core +1 more source
ABSTRACT Purpose Patient activation—encompassing knowledge, confidence, and skills in managing individual's health—is a cornerstone of person‐centered care. However, its significance among childhood, adolescent, and young adult cancer survivors (CAYACS) remains unexplored. This article examines the application of the 13‐item Patient Activation Measure (
Charlotte Demoor‐Goldschmidt +12 more
wiley +1 more source
ABSTRACT Minimal residual disease (MRD) is a central biomarker in multiple myeloma (MM), offering unprecedented sensitivity for evaluating treatment efficacy and serving as a potential surrogate endpoint. We conducted a comprehensive analysis of clinical trials registered on ClinicalTrials.gov between 2014 and 2025.
Mimi Choon‐Quinones +12 more
wiley +1 more source
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance
Different mechanisms have been reported to explain resistance to chemotherapy in cancer. Here, the authors show that the chemotherapeutic drug 5-fluorouracil alters the function of ribosomes to promote pro-survival gene translation leading to ...
Gabriel Therizols +31 more
doaj +1 more source
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König +19 more
wiley +1 more source
What's New? Circulating nuclear DNA (cir‐nDNA)‐based assessment of minimal residual disease (MRD) offers powerful post‐surgery prognostic insight for stage III colon cancer (CC). Sparse knowledge of post‐surgical variations and origins in cir‐nDNA, however, has limited its clinical application.
Andrei Kudriavtsev +17 more
wiley +1 more source
Fertility sparing surgery for ovarian sex cord stromal tumors: a nine case series
Ovarian Sex Cord Stromal Tumors (SCST) are a rare disease carrying a good prognosis. They generally affect young women; therefore fertility preservation is a critical issue.
Montassar Ghalleb +6 more
doaj +1 more source

